The client is a leading pharmaceutical company that develops vaccines and medicines to treat an array of illnesses and medical conditions. The company is consistently ranked among the top 10 pharmaceutical companies on the planet and has facilities worldwide.
Our client was in the process of consolidating its R&D facility in Europe and determined that the majority of equipment in its Mont-Saint-Guibert, Belgium facility was surplus to the ongoing operations.
This two-building facility contained a mix of lab and analytical equipment as well as some pilot scale API equipment; all of which needed to be sold and removed in a timely manner in order to successfully complete its consolidation project.
Given a tight deadline to complete this disposition project, EquipNet opted to deploy a two-tier sales plan that entailed several months of managed pricing by the Direct Sales Force, and an auction event to complete the clearance of the Belgian facility’s assets.
•Project Management • Dedicated Online Auction
•Individual Asset Sales • Worldwide Logistics
By marketing the client’s assets with end-user buyers in mind, EquipNet was able to sell 160 premium assets through the online MarketPlace, and the remaining 150 assets in a webcast auction event. At the project’s end, EquipNet returned more than €2,200,000 in sales proceeds to the client; adhering directly to its provided time frame and going well beyond the client’s expectations.